Market closed
iRhythm/IRTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About iRhythm
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Ticker
IRTC
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,000
Website
iRhythm Metrics
BasicAdvanced
$2.4B
Market cap
-
P/E ratio
-$4.26
EPS
1.22
Beta
-
Dividend rate
Price and volume
Market cap
$2.4B
Beta
1.22
52-week high
$124.12
52-week low
$55.92
Average daily volume
599K
Financial strength
Current ratio
6.921
Quick ratio
6.609
Long term debt to equity
727.057
Total debt to equity
742.567
Interest coverage (TTM)
-12.56%
Management effectiveness
Return on assets (TTM)
-9.36%
Return on equity (TTM)
-81.46%
Valuation
Price to revenue (TTM)
4.35
Price to book
23.81
Price to tangible book (TTM)
24.02
Price to free cash flow (TTM)
-24.38
Growth
Revenue change (TTM)
18.81%
Earnings per share change (TTM)
29.95%
3-year revenue growth (CAGR)
20.58%
3-year earnings per share growth (CAGR)
27.43%
What the Analysts think about iRhythm
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for iRhythm stock.
iRhythm Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
iRhythm Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
iRhythm News
AllArticlesVideos
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
Benzinga·4 days ago
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
GlobeNewsWire·5 days ago
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
GlobeNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for iRhythm stock?
iRhythm (IRTC) has a market cap of $2.4B as of October 26, 2024.
What is the P/E ratio for iRhythm stock?
The price to earnings (P/E) ratio for iRhythm (IRTC) stock is 0 as of October 26, 2024.
Does iRhythm stock pay dividends?
No, iRhythm (IRTC) stock does not pay dividends to its shareholders as of October 26, 2024.
When is the next iRhythm dividend payment date?
iRhythm (IRTC) stock does not pay dividends to its shareholders.
What is the beta indicator for iRhythm?
iRhythm (IRTC) has a beta rating of 1.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.